Modeling the impact of real-world adherence to once-daily (QD) versus twice-daily (BID) non-vitamin K antagonist oral anticoagulants on stroke and major bleeding events among non-valvular atrial fibrillation patients

Colleen A. McHorney, Eric D. Peterson, Veronica Ashton, François Laliberté, Concetta Crivera, Guillaume Germain, Naveed Sheikh, Jeff Schein, Patrick Lefebvre

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Fingerprint

Dive into the research topics of 'Modeling the impact of real-world adherence to once-daily (QD) versus twice-daily (BID) non-vitamin K antagonist oral anticoagulants on stroke and major bleeding events among non-valvular atrial fibrillation patients'. Together they form a unique fingerprint.

Medicine & Life Sciences